Standing Order
Structure Therapeutics Inc.

Dashboard

Structure Therapeutics Inc.

GPCRNASDAQ

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$2.6B
Price$35.9552w $16.20 – $93.79
Conviction2/ 5
Revenue (TTM)$0
Revenue growth YoY-100.0%
P/E (trailing)—
Gross margin—
Operating margin—
Net margin—
52w price change+65.0%
Next earningsNov 5, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Sep 22
    Ownership changeSEC

    SEC Form 4 insider transaction filing by Structure Therapeutics Inc.

  • Sep 8
    OtherSEC

    Structure Therapeutics Inc. filed Form 8-K covering items 7.01, 8.01 and 9.01.

  • Sep 2
    Ownership changeSEC

    Form 4 insider transaction filing

  • Aug 19
    Ownership changeSEC

    SEC Form 4 insider transaction filing

  • Aug 7
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Aug 6
    Financial resultsSEC

    Structure Therapeutics Inc. files 8-K (items 2.02, 9.01) disclosing financial results.

  • Aug 5
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jul 24
    Ownership changeSEC

    SEC Form 4 insider transaction filing dated 2026-07-24.

  • Jul 15
    Ownership changeSEC

    SEC Form 4 filing reporting change in insider beneficial ownership.

  • Jun 29
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 18
    Ownership changeSEC

    SEC Form 4 insider transaction filing on 2026-06-18.

  • Jun 18
    OtherSEC

    8-K filing item 5.07 disclosing results of matters submitted to shareholder vote.

  • Jun 18
    Ownership changeSEC

    SEC Form 4 insider transaction filing dated 2026-06-18.

  • Jun 18
    Ownership changeSEC

    Form 4 insider transaction filing by Structure Therapeutics Inc.

  • Jun 18
    Ownership changeSEC

    SEC Form 4 insider transaction filing

  • Jun 18
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • Jun 18
    Ownership changeSEC

    SEC Form 4 insider transaction filing.

  • May 7
    Securities offeringSEC

    Structure Therapeutics filed Form 424B5 prospectus supplement.

  • May 7
    Financial resultsSEC

    8-K filing (items 1.01,2.02,8.01,9.01) covering material agreement and financial results.

Not financial advice — research and opinion only. Disclosures